Seasoned national laboratory scientist and leader Laura Berzak Hopkins joins PPPL as its new associate laboratory director for strategy and partnerships and deputy chief research officer.
Tag: Science Policy
ASBMB raises concerns about proposed NIH subaward policy
The society is concerned that new NIH subaward policy, if adopted, will harm the global scientific enterprise by disrupting collaboration and heighten administrative burden on scientists.
ASBMB cautions against sacrificing science funds to make debt-ceiling deal
ASBMB emphasizes the importance of preserving research from scientists supported by the NIH, NSF and DOE during debt-ceiling deal
Biden taps Sandia Labs’ senior leader for quantum advisory committee
Deborah Frincke, associate laboratories director of national security programs at Sandia National Laboratories, has been appointed to the National Quantum Initiative Advisory Committee.
Bleak Cyborg Future from Brain-Computer Interfaces if We’re Not Careful
The most promising method to achieve real-world BCI applications is through electroencephalography, a method of monitoring the brain’s electrical activity. EEG-based BCIs will require a number of technological advances prior to widespread use, but more importantly, they will raise a variety of social, ethical, and legal concerns. Researchers conducted a review of modern commercial brain-computer interface devices and discuss the primary technological limitations and humanitarian concerns of these devices in APL Bioengineering.
Healing a wounded world
Brooke Eastman studies how acid rain impacts forest health. She is committed to highlighting forests’ role in mitigating climate change.
Top Pharmacologist Offers Plan to Solve Lingering Disparities in Designing Medicines that Work for All
In a new perspective piece published in the Feb. 5 issue of Science, pharmacologist Namandje Bumpus, Ph.D. — who recently became the first African American woman to head a Johns Hopkins University School of Medicine department, and is the only African American woman leading a pharmacology department in the country — outlines the molecular origins for differences in how well certain drugs work among distinct populations. She also lays out a four-part plan to improve the equity of drug development.
Presidential roundtable discussion: How do we restore science to policy making? Presidential roundtable discussion: How do we restore science to policy making?
Restoring science in the White House is the topic of the presidential roundtable discussion at that the Society for Risk Analysis’ (SRA) Virtual Annual Meeting, on Thursday, December 17 from 12:00 – 1:30 p.m. ET.
Story Tips From Johns Hopkins Experts on COVID-19
Recently, several physicians hosted a press conference in which one physician claimed that the combination of hydroxychloroquine, the antibiotic azithromycin and the mineral zinc could cure COVID-19. The video footage of that press conference went viral on social media, and soon many social media platforms removed the videos for providing inaccurate, non-scientifically backed claims. But questions from the public may still remain.